“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Irvine, California-based Edwards triggered the agreement to repurchase $500 million of its common stock. With this ...

Pleural Dynamics announced today that it completed enrollment in a post-market clinical study for its ACES system.

Masimo (Nasdaq: MASI) announced today that it received FDA 510(k) clearance for expanded indications for its O3 regional ...

Stimvia announced that it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) ...

Align Technology (Nasdaq: ALGN) announced that it filed patent infringement lawsuits against Shanghai-based Angelalign ...

Neurovalens today announced that it closed an investment round worth approximately $8.1 million (£6 million) in proceeds.